Literature DB >> 23732280

Therapy: Immunotherapy for T1DM--targeting innate immunity.

F Susan Wong, Li Wen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23732280      PMCID： PMC4048745          DOI： 10.1038/nrendo.2013.103

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Role of pancreatic beta-cells in the process of beta-cell death.

Authors:  D Pipeleers; A Hoorens; M Marichal-Pipeleers; M Van de Casteele; L Bouwens; Z Ling
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

Review 2.  Blockade of interleukin 1 in type 1 diabetes mellitus.

Authors:  Thomas Mandrup-Poulsen; Linda Pickersgill; Marc Yves Donath
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

3.  Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.

Authors:  Antoinette Moran; Brian Bundy; Dorothy J Becker; Linda A DiMeglio; Stephen E Gitelman; Robin Goland; Carla J Greenbaum; Kevan C Herold; Jennifer B Marks; Philip Raskin; Srinath Sanda; Desmond Schatz; Diane K Wherrett; Darrell M Wilson; Jeffrey P Krischer; Jay S Skyler; Linda Pickersgill; Eelco de Koning; Anette-G Ziegler; Bernhard Böehm; Klaus Badenhoop; Nanette Schloot; Jens Friis Bak; Paolo Pozzilli; Didac Mauricio; Marc Y Donath; Luis Castaño; Ana Wägner; Hans Henrik Lervang; Hans Perrild; Thomas Mandrup-Poulsen
Journal:  Lancet       Date:  2013-04-05       Impact factor: 79.321

Review 4.  The role of inflammasome-derived IL-1 in driving IL-17 responses.

Authors:  Kingston H G Mills; Lara S Dungan; Sarah A Jones; James Harris
Journal:  J Leukoc Biol       Date:  2012-12-27       Impact factor: 4.962

5.  In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18.

Authors:  Li Wen; Elizabeth A Green; Thomas Stratmann; Anaïs Panosa; Ramon Gomis; Elizabeth E Eynon; Richard A Flavell; Jovita A Mezquita; Conchi Mora
Journal:  Eur J Immunol       Date:  2011-04-13       Impact factor: 5.532

Review 6.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

7.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  IL-1 receptor deficiency slows progression to diabetes in the NOD mouse.

Authors:  Helen E Thomas; Windy Irawaty; Rima Darwiche; Thomas C Brodnicki; Pere Santamaria; Janette Allison; Thomas W H Kay
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

9.  Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation.

Authors:  Vitaly Ablamunits; Octavian Henegariu; Jakob Bondo Hansen; Lynn Opare-Addo; Paula Preston-Hurlburt; Pere Santamaria; Thomas Mandrup-Poulsen; Kevan C Herold
Journal:  Diabetes       Date:  2011-10-31       Impact factor: 9.461

10.  Apoptosis of human islet cells by cytokines.

Authors:  Sunshin Kim; Kyoung-Ah Kim; Kyoungho Suk; Yun-Hee Kim; Seung Hoon Oh; Moon-Kyu Lee; Kwang-Won Kim; Myung-Shik Lee
Journal:  Immune Netw       Date:  2012-06-30       Impact factor: 6.303
  10 in total
  1 in total

Review 1.  CD4 T cell differentiation in type 1 diabetes.

Authors:  L S K Walker; M von Herrath
Journal:  Clin Exp Immunol       Date:  2015-07-28       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.